Unpacking the prescription drug provisions of the Inflation Reduction Act of 2022

On 7 August, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant prescription drug-related provisions. The bill generally revives many of the prescription drug provisions proposed last fall in the Build Back Better Act, but with some notable differences.

Join the Hogan Lovells Life Sciences & Health Care team for a three-part webinar series in which they discussed the recent prescription drug legislation:

Part 1: Drug price negotiation program

Click here to watch the recording

Part 2: Medicare Part B and Part D inflation rebates

Click here to watch the recording

Part 3: Medicare Part D redesign

Click here to watch the recording


CLE credit is applicable by attending the live webinar. This program offers CLE credit in California and New York, pending approval of materials. All other attendees may receive a uniform certificate of attendance.

Back To Listing